Galenica AG's latest marketcap:
As of 07/05/2025, Galenica AG's market capitalization has reached $5.57 B. According to our data, Galenica AG is the 3067th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 5.57 B |
Revenue (ttm) | 4.95 B |
Net Income (ttm) | 230.24 M |
Shares Out | 49.83 M |
EPS (ttm) | 4.62 |
Forward PE | 24.31 |
Ex-Dividend Date | 04/14/2025 |
Earnings Date | 08/07/2025 |
Galenica AG's yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/05/2025 | ₣5.57 B | 18.08% | 3067 |
12/30/2024 | ₣3.71 B | 2.23% | 3460 |
12/29/2023 | ₣3.62 B | -3.36% | 3234 |
12/30/2022 | ₣3.75 B | 10.52% | 3198 |
12/30/2021 | ₣3.39 B | 16.56% | 4070 |
12/30/2020 | ₣2.91 B | -1.09% | 3891 |
12/30/2019 | ₣2.94 B | 38.76% | 3461 |
12/28/2018 | ₣2.12 B | -15.24% | 3815 |
12/29/2017 | ₣2.5 B | 3887 |
Company Profile
About Galenica AG
Galenica AG is a leading healthcare service provider based in Switzerland, with operations extending internationally. Founded in 1927 and headquartered in Bern, the company delivers a wide range of healthcare solutions through its two core business segments.
Business Segments
-
Products & Care
This segment manages pharmacies and partner pharmacies under well-known brands such as Amavita, Sun Store, and Coop Vitality. It also includes the specialty pharmacy mediservice. Key offerings include:
- Home-treatment medication for patients
- Development, marketing, and sales of healthcare services and products through diverse distribution channels
-
Logistics & IT
This segment provides specialized pre-wholesale services tailored for pharmaceutical and healthcare companies, including:
- Storage, distribution, and debt collection services
- A master data system for the healthcare market
- Management solutions for pharmacies and healthcare providers
- Internal IT services and technical information publications
- Distribution of former Viatris OTC products
Frequently Asked Questions
-
What is Galenica AG's (SWX-GALE) current market cap?As of 07/05/2025, Galenica AG (including the parent company, if applicable) has an estimated market capitalization of $5.57 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Galenica AG (SWX-GALE) rank globally by market cap?Galenica AG global market capitalization ranking is approximately 3067 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.